BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miura K, Fukuda H, Mineta H, Yamaguchi K, Harada H, Yusa H, Tsutsui Y. Phosphoglyceride crystal deposition disease. Pathology International 2008;50:992-8. [DOI: 10.1046/j.1440-1827.2000.01138.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Ohkura Y, Uruga H, Shiiba M, Ito S, Shimoyama H, Ishihara M, Ueno M, Udagawa H. Phosphoglyceride crystal deposition disease requiring differential diagnosis from malignant tumors and confirmed by Raman spectroscopy: A case report. World J Clin Cases 2022; 10(23): 8304-8311 [DOI: 10.12998/wjcc.v10.i23.8304] [Reference Citation Analysis]
2 Takeuchi K, Tanaka H, Kawamori H, Ohta E, Suzuki M, Shimoura H, Izawa Y, Kodama Y, Hirata K. Severe Functional Tricuspid Stenosis Due to Phosphoglyceride Crystal Deposition Disease in Right Atrium. JACC: Case Reports 2022;4:230-235. [DOI: 10.1016/j.jaccas.2021.09.024] [Reference Citation Analysis]
3 Nakamura T, Fujiwara M, Hara K, Kurosawa K, Miyazaki T. Phosphoglyceride crystal deposition disease involving adnexa uteri: a case report with histogenetic consideration. Pathologica 2021;113:442-8. [PMID: 34974550 DOI: 10.32074/1591-951X-193] [Reference Citation Analysis]
4 Omar N, Mohd Yusof MA, Lee Kwan Min V, Bakrin IH, Awang M, Abdul Muthalib F. Phosphoglyceride crystals deposition disease: a rare pseudosarcomatous growth with peculiar predilections. Pathology 2022. [DOI: 10.1016/j.pathol.2021.10.007] [Reference Citation Analysis]
5 Ishida A, Fujimoto M, Yamada Y, Takei Y, Sakamoto A, Miura K, Minamiguchi S, Haga H. Phosphoglyceride crystal deposition disease in a rib bone and ovary mimicking malignancy: A report of two cases including a previously undescribed cystic case. Pathol Int 2021. [PMID: 34595797 DOI: 10.1111/pin.13169] [Reference Citation Analysis]
6 Nakahara O, Baba H. Phosphoglyceride crystal deposition disease in the abdominal wall: a case report. Surg Case Rep 2018;4:120. [PMID: 30232573 DOI: 10.1186/s40792-018-0516-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tokue H, Ebara M, Takahashi R, Tokue A, Tsushima Y. Phosphoglyceride crystal deposition disease mimicking a malignant tumor. Eur J Radiol Open 2018;5:16-9. [PMID: 29387736 DOI: 10.1016/j.ejro.2018.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li B, Singer NG, Yeni YN, Haggins DG, Barnboym E, Oravec D, Lewis S, Akkus O. A Point-of-Care Raman Spectroscopy-Based Device for the Diagnosis of Gout and Pseudogout: Comparison With the Clinical Standard Microscopy. Arthritis Rheumatol 2016;68:1751-7. [PMID: 26882173 DOI: 10.1002/art.39638] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
9 Yamada Y, Nishioka K, Kajihara H, Noguchi T, Naruse K, Horie K. A case of phosphoglyceride crystal deposition disease in the pelvic soft tissues recurring after initial surgery. Case Rep Obstet Gynecol 2015;2015:751582. [PMID: 25763284 DOI: 10.1155/2015/751582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Li B, Yang S, Akkus O. A customized Raman system for point-of-care detection of arthropathic crystals in the synovial fluid. Analyst 2014;139:823-30. [PMID: 24419093 DOI: 10.1039/c3an02062b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
11 Cheng X, Haggins DG, York RH, Yeni YN, Akkus O. Analysis of crystals leading to joint arthropathies by Raman spectroscopy: comparison with compensated polarized imaging. Appl Spectrosc 2009;63:381-6. [PMID: 19366502 DOI: 10.1366/000370209787944280] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
12 Shoji F, Yoshino I, Kometani T, Yamamoto H, Maehara Y. Phosphoglyceride crystal deposition disease originating from the myocardium. The Journal of Thoracic and Cardiovascular Surgery 2007;134:508-9. [DOI: 10.1016/j.jtcvs.2007.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
13 Nishimura A, Kasai Y, Takegami K, Uchida A. Phosphoglyceride crystal deposition disease in the spine: a case report. J Spinal Disord Tech 2005;18:112-5. [PMID: 15687863 DOI: 10.1097/01.bsd.0000127701.37593.03] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
14 Miura K, Han G, Kondo S, Ohhashi H, Tsutsui Y. Phosphoglyceride (PG) crystal deposition disease: a novel acquired disease in which PG crystals are deposited in injured soft tissue and bone with phospholipid metabolism disturbance. Pathol Int 2004;54:881-9. [PMID: 15598309 DOI: 10.1111/j.1440-1827.2004.01776.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
15 Yachida S, Fukushima N, Nakanishi Y, Nimura S, Sato M, Shimada K, Miura K, Sakamoto M. Phosphoglyceride crystal deposition disease presenting as multiple paragastric masses. Dig Dis Sci 2002;47:1413-8. [PMID: 12064820 DOI: 10.1023/a:1015351320907] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]